financetom
Business
financetom
/
Business
/
Agios Pharmaceuticals' Q4 Loss Widens, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Agios Pharmaceuticals' Q4 Loss Widens, Revenue Rises
Feb 13, 2025 4:39 AM

07:04 AM EST, 02/13/2025 (MT Newswires) -- Agios Pharmaceuticals ( AGIO ) reported a Q4 net loss Thursday of $96.5 million, wider than a loss of $95.9 million a year earlier.

Two analysts polled by FactSet expected a loss of $94.2 million.

Revenue for the quarter ended Dec. 31 was $10.7 million, up from $7.1 million a year earlier.

Analysts surveyed by FactSet expected $9.4 million.

The company said it ended the quarter with $1.5 billion in cash, cash equivalents and marketable securities, up from $806.4 million a year earlier.

Price: 33.49, Change: +0.68, Percent Change: +2.1

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved